Doenças Mitocondriais

Autores

  • Ibrahim E. Nasseh Pós-graduando da Disciplina de Neurologia da Escola Paulista de Medicina – Unifesp
  • Célia H. Tengan Doutora em Medicina da Disciplina de Neurologia da Escola Paulista de Medicina – Unifesp.
  • Beatriz H. Kiyomoto Doutora em Medicina da Disciplina de Neurologia da Escola Paulista de Medicina – Unifesp
  • Alberto Alain Gabbai Professor Titular e Chefe da Disciplina de Neurologia da Escola Paulista de Medicina – Unifesp

DOI:

https://doi.org/10.34024/rnc.2001.v9.8921

Palavras-chave:

Mitocôndria, citocromo-c oxidase, DNA mitocondrial, doenças mitocondriais

Resumo

As doenças mitocondriais são um capítulo relativamente recente no estudo das doenças humanas e seu entendimento fisiopatológico necessita de uma abordagem genética de cada paciente. O correto funcionamento das mitocôndrias depende da interação de dois genomas, o nuclear e o mitocondrial. Nesta revisão oferecemos uma introdução sobre genética mitocondrial, a atual classificação das doenças mitocondriais, discorrendo brevemente sobre as apresentações clínicas

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Ernster L, Ikkos D, Luft R. Enzymic activites of human skeletal muscle mitochondria: A tool in clinical metabolic research. Nature, 184:5, 1959.

Shapira Y, Harel S, Russell A. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr J Med Sci, 13:161-4,1977.

Nass MMK, Nass S. Intramitochondrial fibers with DNA characteristics: I. Fixation and electron staining reactions. J Cell Biol, 19:593, 1963.

Anderson S, Bankier AT, Barrel BG, de Bruijin MH, Couson AR, Drovin J, Eperen IC, Nierlich EP, Roe BA, Sanger F, Shreier PH, Smith AJ, Staden R, Young IG. Sequence and organization of the human, mitochondrial, genome. Nature, 290:457-65, 1981.

Holt IJ, Cooper JM, Morgan-Hughes JA, Harding AE. Deletions of muscle mitochondrial DNA. Lancet, 1:1462, 1988.

Wallace DC, Lott MT, Hodge JA, Schurr TG, Lezza AMS, Elsas II LJ, Nikoskelainen EK. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science, 242:1427-30, 1988.

Mitochondrial encephalomyopathies: gene mutation. Neuromusc Disord, 11:332-7, 2001.

Morgan-Hughes J A Mitochondrial disease. In: Engel AG, Franzini-Armstrong C. Myology – Basic and Clinical 2. ed. USA, Mc Graw Hill International 1994, (2) 1610-60.

Shoffner JM. Oxidative phosphorylation disease diagnosis. Ann NY Acad Sci, 893:42-60, 1999.

Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta, 1364:271-86, 1998.

Rahman S, Blok R, Dahl H-HM, Danks DM, Kirkby DM, Chow CW, Christodoulou J, Thorburn DR. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol, 39:343-51, 1996.

Loeffen J, Smeitink J, Triepels R, Smeets R, Schuelke M, Sengers R, Trijbels F, Hamel B, Mullaart R, van den Heuvel L. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum genet, 63:1598-608, 1998.

Schuelke M, Smeitink J, Mariman E, Loeffen J, Plecko B, Trijbels F, Stockler-Ipsiroglu S, van den Heuvel L. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet, 21:260-1, 1999.

Trielps RH, van den Heuvel LP, Loeffen JLCM, Buskens CAF, Smeets RJP, Gozalbo MFR, Budde SMS, Mariman EC, Wijburg FA, Barth PG, Trijbels JMF, Smeitink JAM. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann Neurol, 45:787-90, 1999.

Van den Heuvel L, Ruitenbeek W, Smeets R, GelmanRohan Z, Elpeleg O, Loeffen J, Trijbels F, Mariman E, de Bruijn D, Smeitink J. Demonstration of a new pathogenic mutation in human complex I deficiency: a 5-bp duplication in the nuclear gene encoding the 18-kD (AQDQ)subunit. Am J Hum Genet, 62:262-8, 1998.

Rivner MH, Shamsnia M, Swift TR, Trefz J, Roesel RA, Carter AL, Yanamura W, Hommes FA. Kearns-Sayre syndrome and complex II deficiency. Neurology, 39:693- 6, 1989.

Haller RG, Henriksson KG, Jorfeld L, Hultman E, Wilbom R, Sahlin K, Areskog NH, Gunder M, Ayyad K, Blomqvist CG, Hall RE, Thuillier P, Kennaway NG, Lewis S. Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect. J Clin Invest, 88:1197-206, 1991.

Rustin P, Lebidois J, Chretien D, Bourgeron T, Piechaud JF, Rotig A, Sidi D, Munnich A. The investigation of respiratory chain disorders using endocardial biopsies. J Inherit Metab Dis, 16:541-4, 1993.

Bourgeron T, Rustin P, Chretien D, Birch-Machin M, Bourgeois M, Viegas-Pequignot E, Munnich A, Rotig A. Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet, 11:144-9, 1995.

Taylor RW, Birch-Machin MA, Schaefer J, Taylor L, Shakir R, Ackerell BAC, Cochran B, Bindoff LA, Jackson MJ, Griffiths P, Turnbull DM. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann Neurol, 39:224-32, 1996.

Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PE, Rubinstein WS, Myers EN, Richard CW, Cornelisse CJ, Devilee P, Devlin B. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science, 287:848-51, 2000.

Burgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain presenting as leukodystrophy in two sisters with Leigh syndrome. Brain Dev, 14:404-8, 1992.

Adams PL, Lightowlwers RN, Turnbull DM. Molecular analysis of cytochrome-c oxidase deficiency in Leigh’s syndrome. Ann Neurol, 41:268-70, 1997.

Valnot I, Kassis J, Chretien D, DE Lonlay P, Parfait B, Munnich A, Kachaner J, Rustin P, Rotig A. A mitochondrial cytochrome-b mutation but no mutations of nuclear encoded subunits in ubiquinol cytochrome-c reductase (complex III) deficiency. Hum Genet, 104:460-6, 1999.

Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, Granatiero M, Zelante L, Gasparini P, Marzella R, Rocchi M, Bayona-Bafaluy MP, Enriquez JA, Uziel G, Bertini E, Dionisi-Vici C, Franco B, Meitinger T, Zeviani M. Mutations of SURF-1 in Leigh disease associated with cytochrome-c oxidase deficiency. Am J Hum Genet, 63:1609-21, 1998.

Papadopoulou LC, Sue SM, Davidson MM, Tanji K, Nishino I, Sadlock Je, Krishna S, Walker W, Selby J, Glerum Dm, Van Coster R, Lyon G, Scalais E, Lebel R, Kaplan P, Shanske S, De Vivo DC, Bonilla E, Hirano M, Dimauro S, Schon EA. Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly

gene. Nat Genet, 23:333-7, 1999.

Valnot I, von Kleist-Retzon JC, Barrientos A, Corbatyuk M, Taanman JW, Mehaye B, Dustin P, Tzagoloff A, Munnich A, Rotig A. A mutation in the human heme A: Farnesyltranferase gene (COX-10) causes cytocrome-c oxidase deficiency. Hum Mol Genet 9:1245-9, 2000.

DiMauro S & Andreu AL. Mutations in mtDNA: are we scraping the bottom of the barrel? Brain Pathol, 10:431- 41, 2000.

Fischer JC, Ruitenbeek W, Gabreels FJ, Janseen AJ, Renier WO, Sengers RCA, Stadhouders AM, ter Laak HJ, Trijbels JM, Veerkamp JH. A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr, 144:441-4, 1986.

Matsuoka T, Maeda H, Goto Y-I, Nonaka I. Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromusc Disord, 1:443-7, 1991.

Ogasahara S, Yorifuji S, Nishikawa Y, Takahashi MKW, Hazama T, Ankamura Y, Hashimoto S, Kono N, Taui S. Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in KearnsSayre syndrome. Neurology, 35:372-7, 1985.

Ziers S, Jahns G, Jerusalem F. Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with opthalmoplegia plus. J Neurol, 236:97-101, 1989.

Boitier E, Degoul F, Desguerre I, Charpentier C, Francois D, Ponsot G, Diry M, Rustin P, Marsac C. A case of mitochondrial encephalopathy associated with a muscle coenzyme Q10 deficiency. J Neurol Sci, 156:41-6, 1998.

Kaukonen J, Juselius J, Tirani V, Kyttala A, Zeviani M, Comi G, Keranen S, Comi GP, Keranen S, Peltonen L,Suoraloinen A. Role of adenine nucleotide tranlocator 1 in mtDNA maintenance. Science, 289:782-5, 2000.

Nishino I, Spinazola A, and Hirano M Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science, 283:589-692, 1999.

Moraes C, Shanske S, Tritschler H, Aprille J, Andretta F, Bonilla E, Schon EA. mtDNA depletion with variable tissue expression: a novel genetic abnormality in mitochondrial diseases. Am J Hum Genet, 48:492-501, 1991.

Schapira AHV. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr Opin Neurol, 9:260-4, 1996.

Gu M, Cooper JM, Gash M, Mann VM, Javoy-Agid F, Schapira AHV. Mitochondrial defect in Huntington’s disease caudate nucleus. Ann Neurol, 39:385-9, 1996.

Bonilla E, Tanji K, Hirano M, Vu TH, DiMauro S, Schon EA. Mitochondrial involvement in Alzheimer’s disease. Biochim Biophys Acta, 1410:171-82, 1999.

Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophis Acta, 1366:151-65, 1998.

Tanaka M, Kovalenko SA, Gong J-S, Borgeld, H-JW, Katsumata K, Hayakawa M, Yoneda M, Ozawa T. Accumulation of deletions and point mutations in mitochondrial genome in degenerative diseases. Ann NY Acad Sci, 786: 102-11, 1996.

Downloads

Publicado

2001-06-30

Como Citar

Nasseh, I. E., Tengan, C. H., Kiyomoto, B. H., & Gabbai, A. A. (2001). Doenças Mitocondriais. Revista Neurociências, 9(2), 60–69. https://doi.org/10.34024/rnc.2001.v9.8921

Edição

Seção

Artigos Originais
Recebido: 2019-02-02
Publicado: 2001-06-30

Artigos mais lidos pelo mesmo(s) autor(es)

<< < 1 2 3 > >>